Tetrahydropyrrolocyclic compound and application thereof
Grant
US12583841B2
Kind: B2
Mar 24, 2026
Assignee
Breakthrough Pharmaceuticals Inc.
Inventors
Wei Wei, Peng Li, Na Gao, Haiying He, Jian Li, Shuhui Chen
Abstract
A tetrahydropyrrolocyclic compound as represented by formula (I), a pharmaceutically acceptable salt thereof, and an application thereof in preparation of a drug for treating a disease related to a selective orexin-2 (OX-2) receptor antagonist, wherein the related disease is selected from insomnia and depression.
CPC Classifications
C07D 403/14
A61K 31/4192
A61K 31/506
A61P 25/20
A61P 25/24
Filing Date
2022-01-27
Application No.
18275251
Claims
11